Stable incidence of systemic vasculitides in Schleswig-Holstein, Germany;Stabile inzidenz systemischer vaskulitiden in Schleswig-Holstein

Deutsches Arzteblatt

Volumn 105, Issue 19, 2008, Pages 355-361

  Herlyn, Karen ^a,b   Hellmich, Bernhard ^a   Gross, Wolfgang L ^a   Reinhold Keller, Eva ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

ANCA associated vasculitides; Epidemiology; Primary systemic vasculitides; Wegener's granulomatosis

Indexed keywords

ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; AORTA ARCH SYNDROME; ARTICLE; CHURG STRAUSS SYNDROME; GERMANY; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; LITHUANIA; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NORWAY; POLYARTERITIS NODOSA; SPAIN; SWEDEN; SYSTEMIC VASCULITIS; TEMPORAL ARTERITIS; UNITED STATES; WEGENER GRANULOMATOSIS;

EID: 45149113668     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2008.0355     Document Type: Article

References (24)

1. Gonzales-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez-Ledo P, Llorca J: The epidemiology of the primary systemic vasculitides in northwest Spain: Implications of the Chapel Hill Consensus Conference Definitions. Arthritis Care & Res 2003; 49: 388-93.
2. Haugenberg G, Bie R, Bendvold A, Strom Larsen A, Johnsen V: Primary vasculitis in a Norwegian Community Hospital: a retrospective study. Clin Rheumatol 1998; 17: 364-8.
3. Tidman M, Olander R, Svalander C, Danielsson D: Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-1995. Organ involvement, ANCA patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med; 1998; 244: 133-41.
4. Watts RA, Gonzales-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DGI: Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 2001; 60: 170-172.
5. Dadoniene J, Kirdaite G, Mackiewicz Z, Rinkevicius A, Haugeberg G: Incidence of primary systemic vasculitides in Vilnius: a universtiy hospital population based study. Ann Rheum Dis 2005; 64: 335-6.
6. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG: The incidence of giant cell arteritis in Olmstedt County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123: 192-4.
7. Carruthers DM, Watts RA, Symmons DPM, Scott DGI: Wegener's granulomatosis - increased incidence or increased recognition? Br J Rheum 1996; 35: 142-5.
8. Lane SE, Scott DGI, Heaton A, Watts RA: Primary renal vasculitis in Norfolk - increasing incidence or increasing recognition? Nephrol Dial Transplant 2000; 15: 23-7.
9. Knight A, Ekbom A, Brandt L, Askling J: Increasing incidence of Wegeners' granulomatosis in Sweden, 1975-2001. J Rheumatol 2006; 33: 2060-3.
10. Koldingsnes W, Nossent H: Epidemiology of Wegener's granulomatosis in Northern Norway. Arthritis Rheum 2000; 43: 2481-7.
11. Jennette JC, Falk RJ, Andrassy K et al.: Nomenclature of systemic vasculitides: proposal of an International Consensus Conference. Arthritis Rheum 1994; 37: 187-92.
12. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R et al.: No differences in the incidences of vasculitides between North and South Germany: first results of the German vasculitis register. Rheumatology 2002; 41: 540-9.
13. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL: Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 2005; 53: 93-9.
14. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G: Incidence studies of systemic lupus erythematosus in Southern Sweden. J Rheumatol 2000; 27: 685-91.
15. Stehen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA: Incidence of systemic sclerosis in Allegheny County, Pennsylvania. Arthritis Rheum 1997; 40: 441-5.
16. Jacobsen DL, Gange SJ, Rose NR, Graham NMH: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-43.
17. Hellmich B, Csernok E, Gross WL: 20 Years with ANCA (antineutrophil cytoplasmic antibodies): from seromarker to major pathogenic player in vasculitis. J Leukocyte Biol 2003; 74: 1-2.
18. Csernok E, Lamprecht P, Gross WL: Diagnostic significance of ANCA in vasculitis. Nat Clin Pract Rheumatol 2006; 2: 174-5.
19. Fries JF, Hunder GG, Bloch DA et al.: The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990; 33: 1135-6.
20. Sanchez AA, Acevedo EM, Sanchez CG et al.: Epidemiology of the primary systemic vasculitides in a Latin-American population. Arthritis Rheum 2006; 54(9) (Suppl): S757.
21. Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, Peel ET, Wood JB: Wegener's granulomatosis. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 1992 83: 427-38.
22. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
23. Matteson EL, Gold KN, Bloch DA, Hunder GG: Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis Criteria Cohort. Am J Med 1996; 101: 129-34.
24. Reinhold-Keller E, Beuge N, Latza U et al.: An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Longterm outcome in 155 patients. Arthritis Rheum 2000; 43: 1021-32.